Abnormal expression and function of PABPC1 have been detected in gliomas and hepatocellular carcinoma, where PABPC1 is highly expressed and enhances tumor cell proliferation [9, 10], although the combination of PABPC1 and BRCA1 has been suggested to have an anti-cancer function in breast cancer [11]. Here, PABPC1 is linked to breast cancer.